A search of the original published work from 1996 to 2007 was done by use of MEDLINE and EMBASE databases. Search terms included: “lactose intolerance”, “disaccharide malabsorption”, “diarrhoea”, “steatorrhoea”, “bile salt malabsorption”, “bacterial overgrowth”, “faecal incontinence”, “pancreatic insufficiency”, “gastrointestinal bleeding”, “argon”, “formalin”, “radiation proctitis OR proctopathy”, “radiation colitis OR colopathy”, “radiation enteritis OR enteropathy”, “prostate”,
ReviewGastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients
Introduction
Researchers have investigated the effects of radiotherapy on some of the complex neurological, hormonal, muscular, immune, and enzyme functions of the human gastrointestinal tract, although definitive studies are few. Almost all information about the cellular and molecular response of the gastrointestinal tract to radiotherapy is derived from animal experiments. However, the relevance of animal studies is unclear because different animals respond to identical irradiation differently and because the doses delivered might not be comparable to those given to humans.
The available data suggest a sequelae of events where oedema progresses to an inflammatory, mainly mucosal, reaction that later extends to the submucosa. These events stimulate regenerative processes, which either induce mucosal repair or develop into severe inflammation with ulceration, finally producing fibrosis. These changes are mediated by a cytokine cascade, which might persist for decades.
Most patients starting pelvic radiotherapy will have normal gastrointestinal function apart from local tumour effects. During radiotherapy, normal tissues that surround the tumour will be exposed to some radiation (figure 1). The rectum and sigmoid are in close physical proximity to the tumour being treated and are at particular risk. The caecum is fairly fixed and may receive a sizeable dose. The transverse colon and small bowel frequently loop down into the pelvis and are at risk, so too is the proximal small bowel and pancreas when para-aortic nodes are irradiated.
Injury to the gastrointestinal tract depends on the type of radiotherapy given, the dose delivered to tissues, the way it is delivered, and how radiation energy dissipates through tissues. Specific doses that lead to an unacceptable risk of macroscopic pathological change in different parts of the gastrointestinal tract are well established. However, neither the doses of radiotherapy that will lead to permanent changes in gastrointestinal physiology, nor which patients are excessively sensitive to radiotherapy because of abnormal DNA-repair genes, are known. Furthermore, smoking; previous abdominal surgery; concomitant chemotherapy; and disorders such as diabetes, hypertension, pelvic inflammatory disease, HIV, connective-tissue disorders, and inflammatory bowel disease may increase the risk of acute and chronic problems after pelvic radiotherapy. There are no adequate data for the degree of risk posed by any of these factors.
The hypothesis underlying this review is that symptoms arise after pelvic radiotherapy because of changes to normal gastrointestinal physiology that are induced by radiotherapy. Although at present pathological changes caused by radiotherapy cannot be reversed, there is no reason why symptoms cannot be treated through identification and correction of physiological deficits that are induced by pathological changes. Here, I will discuss the changes induced in gastrointestinal physiology after pelvic radiotherapy, what symptoms these cause, and possible treatments for these acquired disorders of physiology. I aim to challenge clinicians to adopt a more-positive approach to the management of gastrointestinal symptoms that start after pelvic radiotherapy.
Section snippets
Acute and chronic symptoms
Acute changes in gastrointestinal physiology can occur in any part of the gastrointestinal tract that is exposed to radiotherapy. Some changes may lead to clinical symptoms; others remain subclinical.1 Symptoms tend to start during the second week of treatment (when histological change is probably at a maximum) and peak by the fourth to fifth week (when histological changes are stable or improving).2
Chronic radiation-induced toxic effects are substantially more common than generally recognised.
Loose stool or diarrhoea
Although psychological factors may contribute to episodes of loose stool after pelvic radiotherapy, specific physiological problems can commonly be defined, including small-bowel bacterial overgrowth, bile-salt malabsorption, carbohydrate malabsorption, changes in transit, development of strictures, neoplasia, or new-onset primary inflammatory bowel disease.
Conclusion
In the past few decades, oncology research has focused on improving patient response and survival, and therefore adequate attention has not been paid to the long-term effects of treatment. To expect oncologists to have the expertise to manage all side-effects of cancer treatment is unreasonable, but they can enhance patient quality of life by identifying long-term problems that arise as a result of treatment—especially now that cancer treatment is increasingly effective and that many patients
Search strategy and selection criteria
References (75)
- et al.
Effect of pelvic irradiation on gastrointestinal function
Am J Med
(1993) - et al.
A modified inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading
Int J Radiat Oncol Biol Phys
(2006) - et al.
Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective
Urology
(1996) - et al.
Distressful symptoms after radical radiotherapy for urinary bladder cancer
Radiother Oncol
(2002) - et al.
Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer
Radiother Oncol
(2004) - et al.
The pathogenesis of post-irradiation chronic diarrhoea: measurement of SeHCAT and B12 absorption for differential diagnosis determines treatment
Clin Radiol
(1985) - et al.
Gastrointestinal symptoms after pelvic radiotherapy: is there any role for the gastroenterologist?
Int J Radiol Biol Phys
(2005) - et al.
Is there more than one late radiation proctitis syndrome?
Radiother Oncol
(1999) - et al.
Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy
Gastroenterology
(1995) - et al.
Control of radiation-induced diarrhea with cholestyramine
Int J Radiat Oncol Biol Phys
(1978)
Small-intestinal injury in women who have had pelvic radiotherapy
Lancet
Absence of bile acid malabsorption as a late effect of pelvic irradiation
Int J Radiat Oncol Biol Phys
Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride
Gastroenterology
Clinical and nutritional implications of radiation enteritis
Am J Clin Nutr
Role of the colon in ileal-resection diarrhoea
Lancet
The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984–2000
Radiother Oncol
Increased risk of rectal cancer after prostate radiation: a population-based study
Gastroenterology
Treatment of radiation proctitis with hyperbaric oxygen
Radiother Oncol
Abdominal radiotherapy is a cause for chronic pancreatitis
Gastroenterology
Abdominal radiotherapy and chronic pancreatitis
Gastroenterology
Faecal incontinence—a late side effect of pelvic radiotherapy
Clin Oncol
Topical phenylephrine in the treatment of radiation-induced faecal incontinence
Clin Oncol
Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial
Lancet
Estimation of the incidence of late bladder and rectum complications after high-dose (70–78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms
Int J Radiat Oncol Biol Phys
Rectal bleeding and its management after irradiation for uterine cervical cancer
Int J Radiat Oncol Biol Phys
Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer
Int J Radiat Oncol Biol Phys
How useful are observational reports in the evaluation of interventions for radiation morbidity? An analysis of formalin therapy for late radiation proctitis
Radiother Oncol
Medical management of radiation enteritis—an algorithmic guide
Clin Radiol
Radiotherapy of localised prostate cancer. Analysis of late treatment complications. A prospective study
Radiother Oncol
Chronic fatigue after radiotherapy for carcinoma of the prostate: correlation with anorectal and genitourinary function
Radiother Oncol
The inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are useful to identify gastrointestinal toxicity after pelvic radiotherapy
Br J Cancer
How patients manage gastrointestinal symptoms after pelvic radiotherapy
Aliment Pharmacol Ther
Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population
Cancer
Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields
Acta Oncol
Patient-rating of distressful symptoms after treatment for early cervical cancer
Acta Obstet Gynecol Scand
Bile acids in radiation-induced diarrhea
South Med J
Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology
Gut
Cited by (276)
Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review
2024, International Journal of Radiation Oncology Biology PhysicsX-ray radiation-induced intestinal barrier dysfunction in human epithelial Caco-2 cell monolayers
2023, Ecotoxicology and Environmental SafetyThe effect of nutritional interventions in acute radiation-induced diarrhoea in patients with primary pelvic cancer: A systematic review
2023, Critical Reviews in Oncology/HematologyBoron uptake of boronophenylalanine and the effect of boron neutron capture therapy in cervical cancer cells
2023, Applied Radiation and Isotopes